Clinical Trials Directory

Trials / Unknown

UnknownNCT05057039

The Study of Gut Microbiota in Hypertensive Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Taipei Medical University · Academic / Other
Sex
All
Age
65 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Recent animal and human studies have found the relationship between the composition of the gut microbiota and hypertension, but some studies did not have a detailed evaluation of the diet content, which could be an important effect on gut microbiota. Moreover, most of these studies were finished in Western countries, in which the dietary patterns were significantly different from those in Chinese regions. This study intends to establish Taiwanese local data to explore the differences in the composition of gut microbiota among hypertensive patients and normotensive subjects.

Detailed description

The investigators plan to enroll total 70 hypertensive and normotensive cases from the elderly health examination in Cathay General Hospital, who are aged from 65 to 80 years. Body mass index and blood samples for biochemical analysis such as blood sugar and cholesterol levels are taken, and fecal samples are collected for analysis of gut microbiota, which is characterized by 16S ribosomal RNA gene sequencing. Besides, the diet and nutrients intake are recorded and calculated by licensed dietitian. Through the exploration of gut microbiota in hypertensive patients, the results can be the reference for clinical treatment.

Conditions

Timeline

Start date
2021-09-01
Primary completion
2023-08-31
Completion
2023-12-31
First posted
2021-09-27
Last updated
2023-04-18

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05057039. Inclusion in this directory is not an endorsement.